Search Results

You are looking at 291 - 300 of 2,910 items for :

  • Refine by Access: All x
Clear All
Full access

NCCN Task Force Report: Optimizing Treatment of Advanced Renal Cell Carcinoma With Molecular Targeted Therapy

Gary R. Hudes, Michael A. Carducci, Toni K. Choueiri, Peg Esper, Eric Jonasch, Rashmi Kumar, Kim A. Margolin, M. Dror Michaelson, Robert J. Motzer, Roberto Pili, Susan Roethke, and Sandy Srinivas

carefully selected population than in patients enrolled in clinical trials. If not recognized and managed appropriately, these side effects may interfere with a patient's ability to continue on a treatment regimen, and may lead to poor outcomes or premature

Full access

Single-Arm Longitudinal Study to Evaluate a Decision Aid for Women Offered Neoadjuvant Systemic Therapy for Operable Breast Cancer

Nicholas Zdenkowski, Phyllis Butow, Andrew Spillane, Charles Douglas, Kylie Snook, Mark Jones, Christopher Oldmeadow, Sheryl Fewster, Corinna Beckmore, Frances M. Boyle, and for the Australia and New Zealand Breast Cancer Trials Group

different options. DAs have been shown to help guide patients in such preference-sensitive situations and improve decision-related outcomes, including reducing decisional conflict, increasing patient knowledge, increasing their involvement in decision

Full access

Validation of the Kattan Nomogram for Prostate Cancer Recurrence After Radical Prostatectomy

Rochelle Payne Ondracek, Michael W. Kattan, Christine Murekeyisoni, Changhong Yu, Eric C. Kauffman, James R. Marshall, and James L. Mohler

diagnosis remains difficult. 2 – 5 Genetic and molecular markers for aggressive prostate cancer have improved, 6 , 7 but clinical nomograms continue to provide the most accurate tools to identify patients most likely to experience poor outcomes. 8 – 10

Full access

The Integration of Early Palliative Care With Oncology Care: The Time Has Come for a New Tradition

Jessica R. Bauman and Jennifer S. Temel

/print certificate. Release date: December 12, 2014; Expiration date: December 12, 2015 Learning Objectives Upon completion of this activity, participants will be able to: Describe the mechanisms through which early PC improves patient outcomes

Full access

Current Concepts in the Evaluation and Treatment of Patients With Diffuse Malignant Peritoneal Mesothelioma

Keli Turner, Sheelu Varghese, and H. Richard Alexander

that were independent factors associated with prolonged survival were age of 60 years or younger and complete or near-complete cytoreduction. The pathologic parameters associated with favorable outcome was absence of deep tissue invasion and a history

Full access

Counterpoint: Robot-Assisted Laparoscopic Prostatectomy: Perhaps the Surgical Gold Standard for Prostate Cancer Care

Mark H. Kawachi

: 1738 – 1741 . 14. Menon M Shrivastava A Tewari A . Laparoscopic and robot assisted radical prostatectomy: establishment of a structured program and preliminary analysis of outcomes . J Urol 2002 ; 168 : 945 – 949 . 15. Wolfram

Full access

Health Literacy in Surgical Oncology Patients: An Observational Study at a Comprehensive Cancer Center

Luke D. Rothermel, Claire C. Conley, Anuja L. Sarode, Michael F. Young, Zulema L. Uscanga, McKenzie McIntyre, Jason B. Fleming, and Susan T. Vadaparampil

– 11 Low health literacy is also correlated with lower adherence to care recommendations and screening guidelines 6 , 12 and negatively influences clinical outcomes related to the management of chronic diseases, including asthma, 13 diabetes, 14 , 15

Full access

Brentuximab Vedotin in Patients With Relapsed HIV-Related Lymphoma

Mitul Gandhi and Adam Petrich

seems to confer a definite risk of developing a PTCL compared with the overall population. 5 Clinical outcomes have improved with modern chemoimmunotherapy and HAART in HIV-related DLBCL, with rates of complete remission (CR) and overall survival

Full access

HSR22-178: Real World Outcomes of Cancer Patients With SARS-CoV-2 Infection Receiving Monoclonal Antibodies

Alexa Wilden, Aishwarya Sannareddy, Hetal Patel, Shraddha Kansagra, Gurbakhash Kaur, Praveen Ramakrishnan, Prapti Patel, Ansh Mehta, and Ankit Kansagra

Full access

CLO21-028: Clinical Outcomes for Advanced Hepatocellular Carcinoma Patients Treated With Systemic Agents in Real-World Practice

Karine Tawagi, Diana Maslov, Madhav KC, Danny Markabawi, Suresh Mukkamala, Fady Farag, Helen Yuan, Adi Bamnolker, Rula Saeed, Zoe Blake, Marc Matrana, and Daniel Johnson